Abstract
Herpes simplex virus infections of the central nervous system are associated with significant morbidity in spite of efficacious antiviral therapy. Herpes simplex virus, type 1 (HSV-1), causes focal neurologic findings that are characteristic of temporal lobe localization. Herpes simplex encephalitis occurs in a biphasic age distribution with one-third of the cases less than 20 and the majority of remaining cases over 50. The diagnostic test of choice is the detection of HSV DNA by PCR in the cerebrospinal fluid. Acyclovir is the treatment of choice and is administered for 14–21 days intravenously at a dose of 10 mg/kg every 8 h. Neonatal HSV infections are more frequently caused by HSV-2 than HSV-1, although the number of cases of the latter is increasing. Infection is most frequently acquired intrapartum by contact with infected maternal genital secretions. Approximately 50 % of all newborns with neonatal infection will have central nervous system involvement. Importantly, HSV-2 infections of the central nervous system in neonates have a poorer outcome than those attributable to HSV-1. Therapy of neonatal infection is achieved with high-dose acyclovir that is administered at 20 mg/kg/every 8 h for 14–21 days. Six months of oral acyclovir post-intravenous treatment has resulted in an improved neurologic outcome for children with central nervous system infection. Likely, in the future, combination antiviral approaches will be employed for both adult and pediatric disease in order to improve neurologic outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mettler C. History of medicine. New York, NY: McGraw-Hill (Blakiston); 1947.
Astruc J. De Morbis Venereis Libri Sex. editor. Paris: G. Cavelier; 1736, p. 365.
Gruter W. Das herpesvirus, seine atiologische und klinische bedeutung. Munch Med Wschr. 1924;71:1058.
Goodpasture E. The axis-cylinders of peripheral nerves as portals of entry to the central nervous system for the virus of herpes simplex encephalitis in man. Am J Pathol. 1925;I:11–28.
Commission M. Epidemic encephalitis: etiology, epidemiology, treatment. Report of a survey by the Mathewson Commission. New York, NY: Columbia University Press; 1929.
Smith MG, Lennette EH, Reames HR. Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol. 1941;17:55–68.
Meyer Jr M, Johnson R, Crawford I, Dascomb H, Rogers N. Central nervous system syndromes of “viral” etiology. Am J Med. 1960;29:334–47.
Zarafonetis CJD, Smodel MC, Adams JW, Haymaker V. Fatal herpes simplex encephalitis in man. Am J Pathol. 1944;20(3):429–45.
Nahmias AJ, Dowdle WR. Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol. 1968;10:110–59.
Corey L, Spear P. Infections with herpes simplex viruses. N Engl J Med. 1986;314:686–91.
Nahmias AJ, Roizman B. Infection with herpes simplex viruses 1 and 2. N Engl J Med. 1973;289:667–74. 719–25;81–89.
Whitley RJ. Epidemiology of herpes simplex virus. In: Roizman B, editor. The herpesviruses. New York, NY: Plenum Publishing Company; 1985. p. 1–44.
Whitley RJ, Roizman B. Herpes simplex viruses. Lancet. 2001;357:1513–8.
Boos J, Sporadic EMM, Encephalitis I. Viral encephalitis: pathology, diagnosis and management. Oxford: Blackwell Scientific Publishers; 1986. p. 55–93.
Boos J, Kim JH. Biopsy histopathology in herpes simplex encephalitis and in encephalitis of undefined etiology. Yale J Biol Med. 1984;57:751–5.
Kapur N, Barker S, Burrows EH, Ellison D, Brice J, Illis LS, et al. Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile. J Neurol Neurosurg Psychiatry. 1994;57:1334–42.
Garcia JH, Colon LE, Whitley RJ, Kichara J, Holmes FJ. Diagnosis of viral encephalitis by brain biopsy. Semin Diagn Pathol. 1984;1:71–80.
Cook ML, Stevens JG. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence of intra-axonal transport of infection. Infect Immun. 1973;7:272–88.
Baringer JR. The biology of herpes simplex virus infection in humans. Surv Ophthalmol. 1976;21:171.
Pagano JS. Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation. J Infect Dis. 1975;132:209–23.
Roizman B. An inquiry into the mechanisms of recurrent herpes infections in man. In: Pollard M, editor. Perspectives in virology IV. New York, NY: Harper and Row Publishers; 1968. p. 283.
Roizman B, Sears A. An Inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol. 1987;41:543–71.
Stevens JC. Latent herpes simplex virus and the nervous system. Curr Top Immunol. 1975;70:31–50.
Terni M. Infections due to herpes simplex virus, recurrent disease and problem of latency. G Maln Infett Parassit. 1971;23:433–67.
Baringer JR, Swoveland P. Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med. 1973;288:648–50.
Bastian FO, Rabson AS, Yee CL. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972;178:306.
Hill TJ. Mechanisms involved in recurrent herpes simplex. In: Nahmias A, Dowdle WR, Schinazi R, editors. The human herpesvirus: an interdisciplinary perspective. Amsterdam: Elsevier/North-Holland; 1981. p. 241.
Nesburn AB, Cook ML, Stevens JG. Latent herpes simplex virus isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol. 1972;88:412–7.
Stevens JG, Cook ML. Latent herpes simplex virus in spinal ganglia. Science. 1971;173:843–5.
Stevens JG, Cook ML. Latent herpes simplex virus in sensory ganglia. Perspect Virol. 1974;8:171.
Warren KG, Brown SM, Wrobelwska A, Gilden D, Koprowski H, Subak-Sharpe J. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med. 1978;298:1068–9.
Cushing H. Surgical aspects of major neuralgia of trigeminal nerve: report of 20 cases of operation upon the Gasserian ganglion with anatomic and physiologic notes on the consequences of its removal. JAMA. 1905;44:773–3379. 860–865, 920–929, 1002–8.
Goodpasture EW. Herpetic infections with special reference to involvement of the nervous system. Medicine. 1929;8:223–43.
Carlton CA, Kilbourne ED. Activation of latent herpes simplex by trigeminal sensory-root section. N Engl J Med. 1952;246:172.
Pazin GJ, Ho M, Jannetta PJ. Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis. 1978;138:405–9.
Pazin GJ, Armstrong JA, Lam MT, Tarr GC, Jannetta PJ, Ho M. Prevention of reactivation of herpes simplex virus infection by human leukocyte interferon after operation on the trigeminal route. N Engl J Med. 1979;301:225–30.
Ellison SA, Carlton CA, Rose HM. Studies of recurrent herpes simplex infections following section of the trigeminal nerve. J Infect Dis. 1959;105:161.
Walz MA, Price RW, Nortkins AL. Latent ganglionic infections with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science. 1974;184:1185–7.
Kibrick S, Gooding GW. Pathogenesis of infection with special reference to nervous tissue. Slow, latent and temperate virus infections. NINBD monograph no. 2; 1965. pp 143–54.
Hill TJ, Field HJ, Roome APC. Intra-axonal location of herpes simplex virus particles. J Gen Virol. 1972;15:233–5.
Rector JT, Lausch RN, Oakes JE. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun. 1982;38:168–74.
Segal AL, Katcher AH, Brightman VJ, Miller MF. Recurrent herpes labialis, recurrent aphthous ulcers and the menstrual cycles. J Dent Res. 1974;53:797–803.
Hill TJ. Herpes simplex virus latency. In: Roizman B, editor. The herpesviruses. New York, NY: Plenum Publishing; 1985. p. 175–240.
Baringer JR. Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med. 1974;291:828.
Cabrera CV, Wholenberg C, Openshaw H, Rey-Mendez M, Puga A, Notkins AL. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature. 1980;288:288–90.
Fraser NW, Lawrence WC, Wroblewska A, Gilden DH, Koprowski H. Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci. 1981;78:6461–5.
Selling B, Kibrick S. An outbreak of herpes simplex among wrestlers (herpes gladiatorum). N Engl J Med. 1964;270:979–82.
Warren KG, Gilden DH, Brown SM. Isolation of herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet. 1977;2:637–9.
Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford Jr CA. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Herpes simplex encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982;145:829–36.
Whitley RJ, Lakeman AD, Nahmias AJ, Roizman B. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982;307:1060–2.
Johnson RT, Olson LC, Buescher EL. Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis. Arch Neurol. 1968;18(3):260–4.
Dinn JJ. Transolfactory spread of virus in herpes simplex encephalitis. Br Med J. 1980;281:1392.
Ojeda VJ, Archer M, Robertson TA, Bucens MR. Necropsy study of olfactory portal of entry in herpes simplex encephalitis. Med J Aust. 1983;1:79–81.
Twomey JA, Barker CM, Robinson G, Howell DA. Olfactory mucosa in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 1979;42:983–7.
Whitley RJ. Therapeutic advances for severe and life-threatening herpes simplex virus infections. In: Lopez C, Roizman B, editors. Human herpesvirus infections. New York, NY: Raven; 1986. p. 153–64.
Schlitt M, Lakeman FD, Wilson ER, To A, Acoff R, Harsh GR, et al. A rabbit model of focal herpes simplex encephalitis. J Infect Dis. 1986;153:732–5.
Stroop WG, Schaefer DC. Production of encephalitis restricted to the temporal lobes by experimental reactivation of herpes simplex virus. J Infect Dis. 1986;153:721–31.
Rock DL, Frasher NW. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 1983;302:523–31.
Davis LE, Johnson RT. An explanation for the localization of herpes simplex encephalitis. Ann Neurol. 1979;5:2–5.
Griffith JR, Kibrick S, Dodge PR, Richardson EP. Experimental herpes simplex encephalitis: electroencephalographic, clinical, virologic, and pathologic observations in the rabbit. Electroencephalogr Clin Neurophysiol. 1967;23:263–7.
Barnes DW, Whitley RJ. CNS disease associated with varicella-zoster virus and herpes simplex virus infection. Neurol Clin. 1986;4(1):265–83.
Casanova JL, Tardieu M, Abel L. Genetic predisposition to herpetic meningo-encephalitis in children. Bull Acad Natl Med. 2010;194(6):915–22. Epub 2011/04/26. Predisposition genetique a l'encephalite herpetique chez l'enfant.
Whitley RJ. Herpes simplex viruses. In: Fields BN, Knipe DM, Chanock R, Hirsch M, Melnick J, Monath T, et al., editors. Fields virology. 2nd ed. New York, NY: Raven; 1990. p. 1843–87.
Fife KH, Corey L. Herpes simplex virus. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PJ, Cates W, Lemon SM, et al., editors. Sexually transmitted diseases. 2nd ed. New York, NY: McGraw-Hill Publishers; 1990. p. 941–52.
Whitley RJ. Herpes simplex virus. In: Knipe DM, Howley RM, Grriffin D, Lamb R, Martin M, Straus SE, editors. Fields virology. 4th ed. New York: Lippincott Williams & Wilkins; 2001. p. 2461–509.
Black FL. Infectious diseases in primitive societies. Science. 1975;187:515–8.
Burnet FM, Williams SW. Herpes simplex: new point of view. Med J Aust. 1939;1:637–40.
Dodd K, Johnston LM, Buddingh GJ. Herpetic stomatitis. J Pediatr. 1938;12:95.
Buddingh GH, Schrum DI, Lanier JC, Guidy DJ. Studies of the natural history of herpes simplex infections. Pediatrics. 1953;11:595.
Juretic M. Natural history of herpetic infection. Helv Paediatr Acta. 1966;21:356.
Cesario TC, Poland JD, Wulff H, Chin TD, Wenner HA. Six years experiences with herpes simplex virus in a children’s home. Am J Epidemiol. 1969;90:416–22.
Douglas Jr RG, Couch RB. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970;104:289–95.
Kloene W, Bang FB, Chakroborty SM, Cooper MR, Kulemann H, Shah KV, et al. A two year respiratory virus survey in four villages in West Bengal, India. Am J Epidemiol. 1970;92:307–20.
Komorous JM, Wheeler CE, Briggaman RA, Caro L. Intrauterine herpes simplex infections. Arch Dermatol. 1977;113:918–22.
Lindgren KM, Douglas Jr RG, Couch RB. Significance of herpesvirus hominis in respiratory secretions of man. N Engl J Med. 1968;276:517–23.
Overall Jr JC. Antiviral chemotherapy of oral and genital herpes simplex virus infections. In: Nahmias AJ, Dowdle WR, Schinazi RE, editors. The human herpesviruses: an interdisciplinary perspective. Amsterdam: Elsevier/North-Holland; 1980. p. 447–65.
Stern H, Elek SD, Miller DM, Anderson HF. Herpetic Whitlow, a form of cross-infection in hospitals. Lancet. 1959;2:871.
Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol. 1976;41:498–507.
Scott TF, Steigman AJ, Convey JH. Acute infectious gingivostomatitis: etiology, epidemiology, and clinical pictures of a common disorder caused by the virus of herpes simplex. JAMA. 1941;117:999.
Stavaraky NM, Rawls WE, Chiavetta J, Donner AP, Wanklin JM. Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2. Am J Epidemiol. 1983;118:109–21.
Templeton AC. Generalized herpes simplex in malnourished children. J Clin Pathol. 1970;23:24–30.
Rawls WE, Campione-Piccardo J. Epidemiology of herpes simplex virus type 1 and 2. In: Nahmias A, Dowdle W, Schinazi R, editors. The human herpesviruses: an interdisciplinary perspective. Amsterdam: Elsevier/North-Holland; 1981. p. 137–52.
Bader C, Crumpacker CS, Schnipper LE, Ransel B, Clark JE, Arndt K, et al. The natural history of recurrent facial-oral infection with herpes simplex virus. J Infect Dis. 1978;138:897–905.
Black FL, Hierholzer WJ, Pinheiro F, Evans AS, Woodall JP. Evidence for persistence of infectious agents in isolated human populations. Am J Epidemiol. 1974;100:230–50.
Nahmias AJ, Josey WE, Naib ZM, Luce C, Duffey C. Antibodies to herpesvirus hominis type 1 and 1 in humans. I Patients with genital herpetic infections. Am J Epidemiol. 1970;91:539–46.
Nahmias AJ, Josey WE, Naib ZM, Luce CF, Fuest B. Antibodies to herpesvirus hominis types 1 and 2 in humans. II Women with cervical cancer. Am J Epidemiol. 1970;91:547–52.
Rawls WE, Tompkins WA, Melnick JL. The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol. 1969;89:547–54.
Sawanabori S. Acquisition of herpes simplex virus infection in Japan. Acta Paediatr Jpn Overseas Ed. 1973;15:16.
Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of herpesvirus group. Am J Epidemiol. 1971;94:496–507.
Glezen WP, Fernald GW, Lohr JA. Acute respiratory disease of university students with special references to the etiologic role of herpesvirus hominis. Am J Epidemiol. 1975;101:111–21.
Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis. 1990;162:306–12.
Evans AS, Dick EC. Acute pharyngitis and tonsillitis in University of Wisconsin students. JAMA. 1964;190:699–708.
Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann Intern Med. 1983;98:958–72.
Kalinyak JE, Fleagle G, Docherty JJ. Incidence and distribution of herpes simplex virus types 1 and 2 from genital lesions in college women. J Med Virol. 1977;1:175–81.
Smith IW, Peutherer JR, Robertson DH. Virological studies in genital herpes. Lancet. 1977;2:1089–90.
Wolontis S, Jeansson S. Correlation of herpes simplex virus types 1 and 2 with clinical features of infection. J Infect Dis. 1977;135:28–33.
Bernstein DI, Bellamy AR, Hook 3rd EW, Levin MJ, Wald A, Ewell MG, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis. 2013;56(3):344–51. Epub 2012/10/23.
Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol. 2001;153:912–20.
Institute of Medicine, Committee on issues and priorities for new vaccine development. Appendix I. Prospects for immunizing against Herpes Simplex Virus 1 and 2. New vaccine development establishing priorities: disease of importance in the United States. Washington, DC: National Academy Press; 1985. pp. 280–312.
Corey L, Holmes K, Benedetti J, Critchlow C. Clinical course of genital herpes: Implications for therapeutic trials. In: Nahmias A, Dowdle WR, Schinazi R, editors. The human herpesviruses: an interdisciplinary perspective. Amsterdam: Elsevier/North Holland; 1981. p. 496–502.
Magder LS, Nahmias AJ, Johnson RE, Lee FK, Brooks C, Snowden C. The prevalence and distribution of herpes simplex virus type 1 and 2 antibodies in the United States population. N Engl J Med. 1989;321:7–12.
Ng ABP, Reagin JW, Yen SS. Herpes genitalis–clinical and cytopathologic experience with 256 patients. Obstet Gynecol. 1970;36:645.
Ekwo E, Wong YW, Myers M. Asymptomatic cervicovaginal shedding of herpes simplex virus. Am J Obstet Gynecol. 1979;134:102–3.
Rattray MC, Corey L, Reeves WC, Vontver LA, Holmes KK. Recurrent genital herpes among women: symptomatic versus asymptomatic viral shedding. Br J Vener Dis. 1978;54:262–5.
Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342(12):844–50.
Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45–52.
Adam E, Kaufman RH, Mirkovic RR, Melnick JL. Persistence of virus shedding in asymptomatic women after recovery from herpes genitalis. Obstet Gynecol. 1979;54:171–3.
Naib ZM, Nahmias AJ, Josey WE, Zaki SA. Relation of cytohistopathology of genital herpesvirus infection to cervical anaplasia. Cancer. 1973;33:1452–63.
Becker WB. The epidemiology of herpesvirus infection in three racial communities in Cape Town. S Afr Med J. 1966;40:109–11.
IHMF Monograph, editor. Herpesvirus infections in pregnancy. Management Strategies Workshop and 7th Annual Meeting; 1999; Seville, Spain.
Rawls WE, Adam E, Melnick JL. Geographical variation in the association of antibodies to herpesvirus type 2 and carcinoma of the cervix. In: Biggs PM, de The G, Payne LN, editors. Oncogenesis and herpesviruses. Lyon: Scientific Publication II, International Agency for Research on Cancer; 1972. p. 424–7.
IHMF. Strategies for interrupting the transmission of genital and neonatal HSV infection. Herpes. 2004;11(Supplement 3):129A–86.
Rawls WE, Gardner HL. Herpes genitalis: venereal aspects. Clin Obstet Gynecol. 1972;15:912–8.
Rawls WE, Gardner HL, Flanders RW, Lowry SP, Kaufman RH, Melnick JL. Genital herpes in two social groups. Am J Obstet Gynecol. 1971;110:682–9.
Rawls WE, Garfield CH, Seth P, Adam E. Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer. Cancer Res. 1976;36:829–35.
Chang TW, Fiumara NJ, Weinstein L. Genital herpes: some clinical and laboratory observations. JAMA. 1974;229:544–5.
Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK. Risk of recurrence after first episodes of genital herpes: relation to HSV type and antibody response. N Engl J Med. 1981;305:315–9.
Choi NW, Shettigara PT, Abu-Zeid HA, Nelson NA. Herpesvirus infection and cervical anaplasia: a seroepidemiological study. Int J Cancer. 1977;19:167–71.
Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316:1444–9.
Corey L, Ashley R, Benedetti J, Selke S, editors. The effect of prior HSV-1 infection on the subsequent natural history of genital HSV-2. 28th interscience conference on antimicrobial agents and chemotherapy, 23–26 Oct 1988, Los Angeles, CA.
Longson M. The general nature of viral encephalitis in the United Kingdom. In: Ellis LS, editor. Viral diseases of the central nervous system. London: Bailliere Tindall; 1984. p. 19–31.
Skoldenberg B, Forsgren M, Alestig K, Bergstrom T, Burman L, Dahlqvist E, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: a randomized multicentre study in consecutive Swedish patients. Lancet. 1984;2:707–11.
Corey L, Spear P. Infections with herpes simplex viruses. N Engl J Med. 1986;314:749–57.
Straus S, Rooney JF, Sever JL, Seilding M, Nusinoff-Lehrman S, Cremer K. Herpes simplex virus infection: biology. Treatment and prevention. Ann Intern Med. 1985;103:404–19.
Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988–1997. Clin Infect Dis. 2002;35:175–82.
Whitley RJ, Soong SJ, Linneman Jr C, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. Clinical assessment. JAMA. 1982;247(3):317–20.
Boston Interhospital Virus Study Group and the NIAID Sponsored Cooperative Antiviral Clinical Study, Chien LT, Whitley RJ, et al. Failure of high dose 5-deoxyuridine in the therapy of herpes simplex virus encephalitis: evidence of unacceptable toxicity. N Engl J Med. 1975;292:600–3.
Longson M. Le defi des encephalitis herpetiques. Ann Microbiol (Paris). 1979;130:5.
Longson MM, Bailey AS, Klapper P. Herpes encephalitis. In: Waterson AP, editor. Recent advances in clinical virology. New York, NY: Churchill Livingston; 1980. p. 147–57.
Whitley RJ, Soong S-J, Dolin R, Galasso GJ, Chien LT, Alford Jr CA, et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med. 1977;297:289–94.
Whitley RJ, Soong S-J, Hirsch MS, Karchmer AW, Dolin R, Galasso G, et al. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981;304:313–8.
Whitley RJ. Herpes virus of the central nervous system. International Herpes Management Forum Management Strategies Workshop, Paris. 2003.
Chien LT, Boehm RM, Robinson H, Liu C, Frenkel LD. Characteristic early electroencephalographic changes in herpes simplex encephalitis. Arch Neurol. 1977;34:361–4.
Miller JHD, Coey A. The EEG in necrotizing encephalitis. Electroencephalogr Clin Neurophysiol. 1959;2:582–5.
Radermecker J. Significant electroencephalographic patterns in the detection and follow-up of cranio-cerebral traumas and encephalatides. Electroencephalogr Clin Neurophysiol. 1970;29(1):98.
Smith JB, Westmoreland BF, Reagan TJ, Sandok BA. A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc. 1975;50:469–74.
Enzmann DR, Ransom B, Norman D. Computed tomography of herpes simplex encephalitis. Radiology. 1978;129:419–25.
Zimmerman RD, Russell EJ, Leeds NE, Kaufman D. CT in the early diagnosis of herpes simplex encephalitis. Am J Roentgenol. 1980;134:61–6.
Schlesinger Y, Buller RS, Brunstrom JE, Moran CJ, Storch GA. Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr. 1995;126:234–41.
Rowley A, Lakeman F, Whitley R, Wolinsky S. Rapid detection of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990;335:440–1.
Kimura H, Aso K, Kuzushima K, Hanada N, Shibata M, Morishima T. Relapse of herpes simplex encephalitis in children. Pediatrics. 1992;89:891–4.
Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet. 1991;337(8735):189–92.
Aurelius E, Johansson B, Skoldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol. 1993;39:179–86.
Puchhammer-Stockl E, Heinz FX, Kundi M, Popow-Kraupp T, Grimm G, Millner MM, et al. Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol. 1993;31:146–8.
Shoji H, Koga M, Kusuhara T, Kaji M, Ayabe M, Hino H, et al. Differentiation of herpes simplex virus 1 and 2 in cerebrospinal fluid of patients with HSV encephalitis and meningitis by stringent hybridization of PCR-amplified DNAs. J Neurol. 1994;241:526–30.
Sakrauski A, Weber B, Kessler HH, Pierer K, Doerr HW. Comparison of two hybridization assays for the rapid detection of PCR amplified HSV genome sequences from cerebrospinal fluid. J Virol Methods. 1994;50:175–84.
Lakeman FD, Whitley RJ. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain biopsied patients and correlation with disease. J Infect Dis. 1995;172:857–63.
Whitley RJ, Cobbs CG, Alford CA, Soong SJ, Morawetz R, Benton JW, et al. Diseases that mimic herpes simplex encephalitis: diagnosis, presentation and outcome. JAMA. 1989;5:33–40.
Whitley RJ, Alford Jr CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, et al. Vidarabine versus acyclovir therapy of herpes simplex encephalitis. N Engl J Med. 1986;314:144–9.
Davis LE, McLaren LE. Relapsing herpes simplex encephalitis following antiviral therapy. Ann Neurol. 1983;13:192–5.
Dix RD, Baringer JR, Panitch HS, Rosenberg SH, Hagedorn J, Whaley J. Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol. 1983;13:196–200.
Wang HS, Kuo MF, Huang SC, Chou ML. Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol. 1994;11:341–5.
VanLandingham KE, Marsteller HB, Ross GW, Hayden FG. Relapse of herpes simplex encephalitis after conventional acyclovir therapy. JAMA. 1988;259:1051–3.
Zuelzer WW, Wolf W, Stulbery CS. Herpes simplex virus as the cause of fulminating visceral disease and hepatitis in infancy. Am J Dis Child. 1952;83:421–39.
Whitley RJ. Herpes simplex virus infections of the central nervous system in children. Semin Neurol. 1982;2:87–97.
Baldwin S, Whitley RJ. Intrauterine herpes simplex virus infection. Teratology. 1989;39:1–10.
Florman AL, Gershon AA, Blackett RP, Nahmias AJ. Intrauterine infection with herpes simplex virus: resultant congenital malformation. JAMA. 1973;225:129–32.
Hutto C, Arvin A, Jacobs R, Steele R, Stagno S, Lyrene R, et al. Intrauterine herpes simplex virus infections. J Pediatr. 1987;110:97–101.
South MA, Tompkins WA, Morris CR, Rawls WE. Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr. 1969;75:13–8.
Whitley RJ, Hutto C. Neonatal herpes simplex virus infections. Pediatr Rev. 1985;7:119–26.
Whitley RJ. Herpes simplex virus infections. In: Remington J, Klein J, editors. Infectious diseases of the fetus and newborn infants. 3rd ed. Philadelphia, PA: W. B. Saunders Company; 1990. p. 282–305.
Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. II Herpes simplex virus and varicella-zoster virus infections. N Engl J Med. 1985;313:1327–30.
Corey L. The diagnosis and treatment of genital herpes. JAMA. 1982;248:1041–9.
Nahmias AJ, Keyserling HL, Kerrick GM. Herpes simplex. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: W. B. Saunders Company; 1983. p. 636–78.
Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med. 1987;316:240–4.
Yeager AS, Arvin AM, Urbani LJ, Kemp III JA. Relationship of antibody to outcome in neonatal herpes simplex infections. Infect Immun. 1980;29:532–8.
Kaye EM, Dooling EC. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology. 1981;31:1045–7.
Parvey LS, Chien LT. Neonatal herpes simplex virus infection introduced by fetal monitor scalp electrode. Pediatrics. 1980;65:1150–3.
Brown ZA, Wald A, Morrow RM, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203–9.
Kohl S, West MS, Prober CG, Sullender WM, Loo LS, Arvin AM. Neonatal antibody-dependent cellular cytoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J Infect Dis. 1989;160:770–6.
Dunkle LM, Schmidt RR, O'Connor DM. Neonatal herpes simplex infection possibly acquired via maternal breast milk. Pediatrics. 1979;63:250–1.
Kibrick S. Herpes simplex virus in breast milk. Pediatrics. 1979;64:390–1.
Sullivan-Bolyai JZ, Fife KH, Jacobs RF, Miller Z, Corey L. Disseminated neonatal herpes simplex virus type 1 from a maternal breast lesion. Pediatrics. 1983;71:455–7.
Yeager AS, Ashley RL, Corey L. Transmission of herpes simplex virus from father to neonate. J Pediatr. 1983;103:905–7.
Douglas J, Schmidt O, Corey L. Acquisition of neonatal HSV-1 infection from a paternal source contact. J Pediatr. 1983;103:908–10.
Linnemann Jr CC, Buchman TG, Light IJ, Ballard JL, Roizman B. Transmission of herpes simplex virus type-1 in a nursery for the newborn: identification of viral species isolated by DNA fingerprinting. Lancet. 1978;1:964–6.
Light IJ. Postnatal acquisition of herpes simplex virus by the newborn infant: a review of the literature. Pediatrics. 1979;63:480–2.
Hammerberg O, Watts J, Chernesky M, Luchsinger I, Rawls W. An outbreak of herpes simplex virus type 1 in an intensive care nursery. Pediatr Infect Dis. 1983;2:290–4.
Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 1971;110:825–36.
Arvin AM, Yeager AS, Bruhn FW, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr. 1982;100:715–21.
Whitley RJ, Nahmias AJ, Visitine AM, Fleming CL, Alford Jr CA. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980;66:489–94.
Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics. 1984;73:188–93.
Mizrahi EM, Tharp BR. A unique electroencephalogram pattern in neonatal herpes simplex virus encephalitis. Neurology. 1981;31:164.
Whitley RJ, Nahmias AJ, Soong S-J, Galasso GG, Fleming CL, Alford Jr CA, et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980;66:495–501.
Guttman LT, Wilfert CM, Eppes S. Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration. J Infect Dis. 1986;154:415–21.
Nahmias AJ, Visitine A, Caldwell A, Wilson C. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol. 1976;21:100–5.
Nahmias A, Hagler W. Ocular manifestations of herpes simplex in the newborn. Int Ophthalmol Clin. 1972;12:191–213.
Reested P, Hansen B. Chorioretinitis of the newborn with herpes simplex type 1: report of a case. Acta Ophthalmol. 1979;57:1096–100.
Cibis A, Burde RM. Herpes simplex virus induced congenital cataracts. Arch Ophthalmol. 1971;85:220–3.
Kimberlin DW, Lakeman FD, Arvin AM, Prober CG, Corey L, Powell DA, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1996;174(6):1162–7. Epub 1996/12/01.
Corey L. Laboratory diagnosis of herpes simplex virus infections. Principles guiding the development of rapid diagnostic tests. Diagn Microbiol Infect Dis. 1986;4(3 Suppl):111S–9. Epub 1986/03/01.
Boehm FH, Estes W, Wright PE, Growdon Jr JF. Management of genital herpes simplex virus infection occurring during pregnancy. Am J Obstet Gynecol. 1980;141:735–40.
International Herpes Management Forum. Strategies for interrupting the transmission of genital and neonatal HSV infection. Herpes. 2004;11 Suppl 3:A129–86.
Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J. 1996;15(3):247–54. Epub 1996/03/01.
Hardy DA, Arvin AM, Yasukawa LL, Bronzan RN, Lewinsohn DM, Hensleigh PA, et al. Use of polymerase chain for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women in delivery. J Infect Dis. 1990;162:1031–5.
Whitley RJ, Corey L, Arvin A, Lakeman FD, Sumaya CV, Wright PF, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988;158:109–16.
Whitley RJ. Herpes simplex virus infections of the central nervous system: a review. Am J Med. 1988;85:61–7.
Whitley RJ, Yeager A, Kartus P, Bryson Y, Connor JD, Alford Jr CA, et al. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics. 1983;72:778–85.
Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230–8. Epub 2001/08/03.
Whitley RJ, Arvin A, Prober C, Burchett S, Corey L, Powell D, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324:444–9.
Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Frenkel LM, Gruber WC, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001;108(2):223–9. Epub 2001/08/03.
Whitley RJ, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med. 1991;324:450–4.
Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284–92. Epub 2011/10/14.
Acknowledgments
Some or all of the research reported in this chapter was supported by the National Center for Advancing Translational Research of the National Institutes of Health through the UAB Center for Clinical and Translational Science under award number UL1TR00165.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Whitley, R.J. (2014). Herpes Simplex Virus Infections of the Central Nervous System. In: Peterson, P., Toborek, M. (eds) Neuroinflammation and Neurodegeneration. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1071-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1071-7_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1070-0
Online ISBN: 978-1-4939-1071-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)